Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasma sphingolipid abnormalities in neurodegenerative diseases

16 Dec 2022

Abstract excerpt

BACKGROUND: In recent years, there has been increasing evidence that several lipid metabolism abnormalities play an important role in the pathogenesis of neurodegenerative diseases. However, it is still unclear which lipid metabolism abnormalities play the most important role in neurodegenerative diseases. Plasma lipid metabolomics (lipidomics) has been shown to be an unbiased method that can be used to explore...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lysosomal Storage Disorders Research
Share to Metabolomics and Mass Spectrometry Studies
Share to Sphingolipid Metabolism and Signaling

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36525454
DOI: 10.1371/journal.pone.0279315

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasma sphingolipid abnormalities in neurodegenerative diseasesPMID 36525454Read ↗

Plasma lipidome dysregulation in frontotemporal dementia reveals shared, genotype-specific, and severity-linked alterations.Semantic proximity Read ↗

Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study.Semantic proximity Read ↗

Multi-Omic Analysis Reveals Lipid Dysregulation Associated with Mitochondrial Dysfunction in Parkinson’s Disease BrainSemantic proximity Read ↗

Plasma lipidome dysregulation in frontotemporal dementia reveals shared, genotype-specific, and severity-linked alterationsSemantic proximity Read ↗

Neurodegenerative Disorders: Spotlight on SphingolipidsSemantic proximity Read ↗

Cerebrospinal fluid neutral lipids are associated with Alzheimer’s disease progressionSemantic proximity Read ↗

Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative DisordersSemantic proximity Read ↗

Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics.Semantic proximity Read ↗

Particular CSF sphingolipid patterns identify iNPH and AD patientsSemantic proximity Read ↗

Clinical Sphingolipids Pathway in Parkinson’s Disease: From GCase to Integrated-Biomarker DiscoverySemantic proximity Read ↗

Glycosphingolipids in Dementia: Insights from Mass Spectrometry and Systems Biology ApproachesSemantic proximity Read ↗

The Multiple Roles of Sphingomyelin in Parkinson's Disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.